AD can reduce the secretion of ghrelin in the brain, and the increase of ghrelin can promote the synaptic plasticity of AD patients, save memory defects, and inhibit excessive inflammatory response (Russo et al., 2022). Here, GHRL is linked to Alzheimer disease.